Wilms' Tumor Gene (WT1) Expression Correlates with Vascular Epithelial Growth Factor (VEGF) in Newly Acute Leukemia Patients Undergoing Chemotherapy
Open Access
- 28 November 2014
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (21) , 9217-9223
Abstract
Wilms' Tumor Gene (WT1) Expression Correlates with Vascular Epithelial Growth Factor (VEGF) in Newly Acute Leukemia Patients Undergoing Chemotherapy WT1;VEGF;acute leukemia;chemotherapy; Background: Today, leukemia is one of the biggest problems worldwide. The Wilms' tumor gene (WT1) and the vascular endothelial growth factor (VEGF) gene are highly expressed in patients with various cancers. This study concerned the relationship between expression of WT1 and VEGF in patients with acute leukemia. Materials and Methods: We evaluated expression of WT1 mRNA and VEGF mRNA using real-time quantitative RT-PCR in the peripheral blood (PB) of 8 newly diagnosed AML and 4 newly diagnosed ALL patients, serially monitored for 2 months. A further 12 normal PB samples served as controls. Results: In the patient group, in comparison with the normal ranges, WT1 and VEGF gene expression was increased, the average values for the expression of these two genes being $0.2852{\pm}0.11$ and $0.2029{\pm}0.018$, respectively. While was no significant relevance between the two genes pre-treatment, a positive link between the two genes in 75% of patients with AML was noted during the procedure of chemotherapy, whereas in 75% of patients with ALL an antiparallel association was observed. Conclusions: Leukemia is associated with production of WT1, which may affect the expression of VEGF.
Keywords
This publication has 38 references indexed in Scilit:
- Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyHaematologica, 2008
- Wilms’ tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosisEuropean Journal of Cancer, 2008
- RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell lineMelanoma Research, 2007
- Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationOncogene, 2007
- Biological Aspects and Binding Strategies of Vascular Endothelial Growth Factor in Renal Cell CarcinomaClinical Cancer Research, 2007
- Wilms' tumour gene 1 (WT1) in human neoplasiaLeukemia, 2005
- Overexpression of the Wilms' tumor gene WT1 in de novo lung cancersInternational Journal of Cancer, 2002
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell GrowthJapanese Journal of Cancer Research, 1999
- Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patientsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- WT-1 is required for early kidney developmentCell, 1993